Whitehawk Therapeutics (WHWK) Total Non-Current Liabilities (2020 - 2024)
Historic Total Non-Current Liabilities for Whitehawk Therapeutics (WHWK) over the last 5 years, with Q3 2025 value amounting to $9.8 million.
- Whitehawk Therapeutics' Total Non-Current Liabilities fell 4008.03% to $9.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.8 million, marking a year-over-year decrease of 4008.03%. This contributed to the annual value of $17.6 million for FY2024, which is 3521.74% down from last year.
- Whitehawk Therapeutics' Total Non-Current Liabilities amounted to $9.8 million in Q3 2025, which was down 4008.03% from $8.8 million recorded in Q2 2025.
- In the past 5 years, Whitehawk Therapeutics' Total Non-Current Liabilities registered a high of $27.2 million during Q4 2023, and its lowest value of $8.8 million during Q2 2025.
- In the last 5 years, Whitehawk Therapeutics' Total Non-Current Liabilities had a median value of $17.0 million in 2024 and averaged $16.7 million.
- In the last 5 years, Whitehawk Therapeutics' Total Non-Current Liabilities crashed by 3521.74% in 2024 and then tumbled by 4008.03% in 2025.
- Over the past 5 years, Whitehawk Therapeutics' Total Non-Current Liabilities (Quarter) stood at $21.5 million in 2021, then dropped by 7.94% to $19.8 million in 2022, then soared by 37.54% to $27.2 million in 2023, then crashed by 35.22% to $17.6 million in 2024, then crashed by 44.16% to $9.8 million in 2025.
- Its Total Non-Current Liabilities stands at $9.8 million for Q3 2025, versus $8.8 million for Q2 2025 and $12.3 million for Q1 2025.